Insider · CIK 0001829252
Garg Pushkal
officer
Files at ALNY (ALNYLAM PHARMACEUTICALS, INC.). First filing Nov 27, 2024, latest Dec 13, 2024.
Track record
Not enough history
Fewer than three past buys with six months of prices.
Median 6-month excess
-
after past buys, n = 0
Hit rate
-
past buys that beat the index over 6 months
Open-market trades
0 / 2
$0 bought, $862k sold
Signals
This insider’s open-market buys and sells, scored.
| Score | Side | Company | Value | Shares | Holdings change | Price context | Filed |
|---|---|---|---|---|---|---|---|
| 17Weak | sell10b5-1 | ALNY ALNYLAM PHARMACEUTICALS, INC. | $440k | 1,752 | -10% | - | |
| 46Moderate | sell 5 | ALNY ALNYLAM PHARMACEUTICALS, INC. | $422k | 1,682 | -9% | - |
Transactions
Every row this insider has filed, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Dec 12, 2024 | ALNY ALNYLAM PHARMACEUTICALS, INC. | SOpen-market sale Common Stock10b5-1 | -121 | $247.48 | $30k | 17,336 | Dec 13, 2024 |
| Dec 12, 2024 | ALNY ALNYLAM PHARMACEUTICALS, INC. | SOpen-market sale Common Stock10b5-1 | -186 | $248.99 | $46k | 17,150 | Dec 13, 2024 |
| Dec 12, 2024 | ALNY ALNYLAM PHARMACEUTICALS, INC. | SOpen-market sale Common Stock10b5-1 | -426 | $250.08 | $107k | 16,724 | Dec 13, 2024 |
| Dec 12, 2024 | ALNY ALNYLAM PHARMACEUTICALS, INC. | SOpen-market sale Common Stock10b5-1 | -778 | $251.68 | $196k | 15,946 | Dec 13, 2024 |
| Dec 12, 2024 | ALNY ALNYLAM PHARMACEUTICALS, INC. | SOpen-market sale Common Stock10b5-1 | -100 | $252.94 | $25k | 15,846 | Dec 13, 2024 |
| Dec 12, 2024 | ALNY ALNYLAM PHARMACEUTICALS, INC. | SOpen-market sale Common Stock10b5-1 | -140 | $254.37 | $36k | 15,706 | Dec 13, 2024 |
| Dec 12, 2024 | ALNY ALNYLAM PHARMACEUTICALS, INC. | SOpen-market sale Common Stock10b5-1 | -1 | $255.80 | $256 | 15,705 | Dec 13, 2024 |
| Nov 25, 2024 | ALNY ALNYLAM PHARMACEUTICALS, INC. | AGrant or award Common Stock | +3,434 | $0.00 | $0 | 19,139 | Nov 27, 2024 |
| Nov 26, 2024 | ALNY ALNYLAM PHARMACEUTICALS, INC. | SOpen-market sale Common Stock | -30 | $247.77 | $7,433 | 19,109 | Nov 27, 2024 |
| Nov 26, 2024 | ALNY ALNYLAM PHARMACEUTICALS, INC. | SOpen-market sale Common Stock | -246 | $249.60 | $61k | 18,863 | Nov 27, 2024 |
| Nov 26, 2024 | ALNY ALNYLAM PHARMACEUTICALS, INC. | SOpen-market sale Common Stock | -364 | $250.68 | $91k | 18,499 | Nov 27, 2024 |
| Nov 26, 2024 | ALNY ALNYLAM PHARMACEUTICALS, INC. | SOpen-market sale Common Stock | -945 | $251.42 | $238k | 17,554 | Nov 27, 2024 |
| Nov 26, 2024 | ALNY ALNYLAM PHARMACEUTICALS, INC. | SOpen-market sale Common Stock | -97 | $252.27 | $24k | 17,457 | Nov 27, 2024 |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.